BSE filing, NSE: RPTECH. Summary written from the filing by ALFA Finder's alert engine.
Rashi Peripherals Ltd: key numbers
- Share price
- ₹865.00
- Market cap
- ₹5,744 Cr
- Revenue (annual)
- ₹15,827 Cr
- Net profit (annual)
- ₹277.6 Cr
- P/E (TTM)
- 18.0×Sector 46.5×
- Promoter holding
- 63.54%-0.49% QoQ
- FII holding
- 3.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rashi Peripherals Ltd
All →Rashi Peripherals Results Update
Rashi Peripherals posted record Q2 FY27 profit of INR 1,307 million, up 120.8% year-on-year. Half-year net profit rose 94.6% to INR 2,353 million.
Rashi Peripherals Merger & Restructuring
Rashi Peripherals' board approved a share purchase and shareholders' agreement to sell 26% of subsidiary Rashi Semiconductor Solutions to Restar Corporation, Japan. Execution remains subject to approvals.
Rashi Peripherals Q2 FY27 Results: Net Profit ₹130.7 Cr, Up 120.8% YoY
Rashi Peripherals Ltd reported revenue from operations of ₹6,185 Cr (+48.8% YoY) and net profit of ₹130.7 Cr (+120.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹130.7 Cr · +120.8% YoY
Rashi Peripherals Legal & Regulatory
Rashi Peripherals received a customs order confirming a demand of Rs 2.15 Crore, including penalty, on its import classification. The company is considering an appeal before CESTAT.
- Value
- ₹2.15 Cr
Rashi Peripherals Earnings Call Transcript: Key Takeaways
Management reported a record-breaking quarter, driven by a global PC refresh cycle and strategic pivot toward integrated services and semiconductors.
- Call
- Guides 20% growth
Rashi Peripherals Board Meeting Date
Rashi Peripherals scheduled a board meeting for November 5, 2026, to approve Q2/HY2 financial results. The agenda proposes capital increase and fund-raising options.
Other management change announcements
All →Paras Healthcare Management Change
Paras Healthcare's board confirmed continuation of Mr. Kabir Kishin Thakur as Non-Executive Non-Independent Director under Regulation 17(1D), effective 5 November 2026. The outcome was reported after a board meeting held the same day.
Organic Coatings Management Change
Organic Coatings appointed Tejas Rajeshbhai Basrani as Chief Financial Officer, effective November 5, 2026. He brings over 15 years of finance, accounts and compliance experience.
Shriram Asset Management Company Management Change
Shriram Asset Management's board appointed Vikrant Gugnani as Executive Director (WTD) for 36 months from November 16, 2026. Two fund managers and a Principal Officer (PMS) were also appointed as senior management, effective November 6, 2026.
- Execution
- 36 months from 2026-11-16
Time Technoplast Management Change
Time Technoplast's board re-appointed Bharat Kumar Vageria as Executive Director and MD for 60 months from February 6, 2027. The filing reports a management reappointment only, with no financial figures.
- Execution
- 60 months from 2027-02-06
Laxmi Organic Industries Management Change
Laxmi Organic appointed Rajesh Naik as Executive Director (Operations) for five years. He brings 34 years of chemical industry experience, including senior BASF leadership.
- Execution
- 60 months
Vaishali Pharma Management Change
Vaishali Pharma appointed Rohil Desai and Ketur Shah as independent directors, subject to shareholder approval. The board deferred a preferential issue proposal without any decision.